Mankind Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 2,686.45 | 2,605.58 | 2,345.91 |
| Operating Expense | 1,915.59 | 1,868.29 | 1,649.67 |
| Net Profit | 458.90 | 412.76 | 382.46 |
| Net Profit Margin | 17.08 | 15.84 | 16.30 |
| Earning Per Share | 11.12 | 10 | 9.27 |
| EBIDTA | 802.67 | 748.53 | 743.02 |
| Effective Tax Rate | 12.65 | 12.50 | 13.37 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 2686.45 |
| Operating Expense | 1915.59 |
| Net Profit | 458.90 |
| Net Profit Margin | 17.08 |
| Earning Per Share | 11.12 |
| EBIDTA | 802.67 |
| Effective Tax Rate | 12.65 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 9,497.80 | 9,264.81 | 8,127.15 |
| Operating Expenses Annual | 6,935.25 | 6,939.70 | 6,429.77 |
| Operating Profit Annual | 3,116.99 | 2,591.74 | 1,860.16 |
| Interest Annual | 371.76 | 14.57 | 27.75 |
| Depreciation | 194.13 | 155.62 | 111.13 |
| Net Profit Annual | 1,884.25 | 1,823.41 | 1,248.26 |
| Tax Annual | 421.74 | 436.16 | 314.58 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 9,497.80 |
| Operating Expenses Annual | 6,935.25 |
| Operating Profit Annual | 3,116.99 |
| Interest Annual | 371.76 |
| Depreciation | 194.13 |
| Net Profit Annual | 1,884.25 |
| Tax Annual | 421.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 211.62 | 134.13 | 86.17 |
| Cash Flow from Operations | 2,322.16 | 1,982.97 | 1,798.99 |
| Cash Flow from Investing | -12,178.83 | -1,919.22 | -1,040.61 |
| Cash Flow from Financing | 9,845.34 | -8.68 | -710.41 |
| Cash Flow at the End | 200.29 | 189.20 | 134.13 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 211.62 |
| Cash Flow from Operations | 2,322.16 |
| Cash Flow from Investing | -12,178.83 |
| Cash Flow from Financing | 9,845.34 |
| Cash Flow at the End | 200.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 28.95 | 27.90 | 22.89 |
| PBIT Margin (%) | 24.97 | 24.02 | 19.58 |
| PBT Margin (%) | 24.90 | 22.60 | 18.89 |
| Net PROFIT Margin (%) | 20.48 | 21.74 | 15.36 |
| Return On Networth / Equity (%) | 13.89 | 20.25 | 17.43 |
| Return On Networth /Employed (%) | 14.88 | 23.35 | 20.91 |
| Return On Assets (%) | 12.29 | 21.09 | 16.43 |
| Total Debt / Equity (X) | 0.30 | TBA | 0.05 |
| Asset Turnover Ratio (%) | 0.60 | 0.97 | 1.07 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 28.95 |
| PBIT Margin (%) | 24.97 |
| PBT Margin (%) | 24.90 |
| Net PROFIT Margin (%) | 20.48 |
| Return On Networth / Equity (%) | 13.89 |
| Return On Networth /Employed (%) | 14.88 |
| Return On Assets (%) | 12.29 |
| Total Debt / Equity (X) | 0.30 |
| Asset Turnover Ratio (%) | 0.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 3,486.82 | 3,473.77 | 3,193.85 |
| Total Current Assets Annual | 4,696.01 | 5,490.41 | 3,516.91 |
| Non Current Assets Annual | 19,132.31 | 5,927.30 | 5,854.21 |
| Total Shareholders Funds Annual | 14,640.27 | 9,623.81 | 7,783.91 |
| Total Assets Annual | 23,828.32 | 11,417.71 | 9,371.12 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 3,486.82 |
| Total Current Assets Annual | 4,696.01 |
| Non Current Assets Annual | 19,132.31 |
| Total Shareholders Funds Annual | 14,640.27 |
| Total Assets Annual | 23,828.32 |
EPS (INR)
Expected
12.39
Reported
12.39
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.10%
